DE68921184T2 - Enzym-Quantifizierungstest auf einem Docht. - Google Patents

Enzym-Quantifizierungstest auf einem Docht.

Info

Publication number
DE68921184T2
DE68921184T2 DE68921184T DE68921184T DE68921184T2 DE 68921184 T2 DE68921184 T2 DE 68921184T2 DE 68921184 T DE68921184 T DE 68921184T DE 68921184 T DE68921184 T DE 68921184T DE 68921184 T2 DE68921184 T2 DE 68921184T2
Authority
DE
Germany
Prior art keywords
analyte
fragment
enzyme
complementary
support
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68921184T
Other languages
English (en)
Other versions
DE68921184D1 (de
Inventor
Pyare L Khanna
Glenda L Choate
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics Corp
Original Assignee
Microgenics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microgenics Corp filed Critical Microgenics Corp
Publication of DE68921184D1 publication Critical patent/DE68921184D1/de
Application granted granted Critical
Publication of DE68921184T2 publication Critical patent/DE68921184T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
DE68921184T 1988-12-29 1989-12-28 Enzym-Quantifizierungstest auf einem Docht. Expired - Fee Related DE68921184T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29145788A 1988-12-29 1988-12-29

Publications (2)

Publication Number Publication Date
DE68921184D1 DE68921184D1 (de) 1995-03-23
DE68921184T2 true DE68921184T2 (de) 1995-08-31

Family

ID=23120370

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68921184T Expired - Fee Related DE68921184T2 (de) 1988-12-29 1989-12-28 Enzym-Quantifizierungstest auf einem Docht.

Country Status (7)

Country Link
EP (1) EP0376707B1 (de)
JP (1) JP2667718B2 (de)
AT (1) ATE118617T1 (de)
AU (1) AU615780B2 (de)
CA (1) CA1336163C (de)
DE (1) DE68921184T2 (de)
ES (1) ES2070917T3 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708929A (en) * 1984-10-29 1987-11-24 Microgenics Corporation Methods for protein binding enzyme complementation assays
AU5280086A (en) * 1985-01-30 1986-08-07 Genetic Diagnostics Corp. Self timed immunoassay device
EP0271204A3 (de) * 1986-11-07 1989-10-25 Syntex (U.S.A.) Inc. Immunochromatographische Methode und Vorrichtung
AU610281B2 (en) * 1987-09-21 1991-05-16 Roche Diagnostics Corporation Solid-phase non-separation enzyme assay

Also Published As

Publication number Publication date
EP0376707A2 (de) 1990-07-04
JPH02201265A (ja) 1990-08-09
EP0376707B1 (de) 1995-02-15
EP0376707A3 (en) 1990-10-31
AU3993089A (en) 1990-07-05
JP2667718B2 (ja) 1997-10-27
ATE118617T1 (de) 1995-03-15
ES2070917T3 (es) 1995-06-16
AU615780B2 (en) 1991-10-10
DE68921184D1 (de) 1995-03-23
CA1336163C (en) 1995-07-04

Similar Documents

Publication Publication Date Title
DE3852996D1 (de) Immunoassayverfahren zum Nachweis von Antigenen.
CA2007532A1 (en) Threshold ligand-receptor assay
CA2217818A1 (en) Chemiluminescent immunoassay for antibody detection
ES2187622T3 (es) Reactivos y dispositivos de ensayo.
AU7727491A (en) Improvements in or relating to methods for providing internal references for use in analyte-receptor assays
EP0375422A3 (de) Zusammensetzung und Methoden zur Bestimmung der Anwesenheit von Amphetaminen in einer Probe, die in Verdacht steht, Amphetamine und/oder Metamphetamine zu enthalten
EP0214847A3 (en) Squarate dye conjugate, process for making it and its use in assay methods and kits
ATE221997T1 (de) Immunoassays zum nachweis von antiphospholipid- antikörpern
DE3579841D1 (de) Multisites immunometrisches testverfahren.
AU629886B2 (en) Diagnostic test using chimeric antibodies
GB2001172A (en) Competitive protein binding assay
ATE74662T1 (de) Immunoanalysetestverfahren fuer cholesterolepoxide.
ES2023868B3 (es) Procedimiento de determinacion inmunometrico
DE68921184D1 (de) Enzym-Quantifizierungstest auf einem Docht.
EP0387027A3 (de) Methode und Reagenz zur Diagnose von Endometriose
EP0380019A3 (de) Fluoreszenz-Polarisationsimmunoassay für Methadon
CA2213083A1 (en) Detection of antibody production
DE3851221T2 (de) Nichttrennender festphasen-enzymtest.
ATE256291T1 (de) Immunologische bestimmungsmethode
KR890006828A (ko) 효소 분석법
ATE208041T1 (de) A-protein als diagnostikum für krebs
KR940000871A (ko) 한국형 c형 간염의 진단 방법 및 진단키트

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ROCHE DIAGNOSTICS CORP., INDIANAPOLIS, IND., US

8339 Ceased/non-payment of the annual fee